DE602006010934D1 - Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika - Google Patents

Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika

Info

Publication number
DE602006010934D1
DE602006010934D1 DE602006010934T DE602006010934T DE602006010934D1 DE 602006010934 D1 DE602006010934 D1 DE 602006010934D1 DE 602006010934 T DE602006010934 T DE 602006010934T DE 602006010934 T DE602006010934 T DE 602006010934T DE 602006010934 D1 DE602006010934 D1 DE 602006010934D1
Authority
DE
Germany
Prior art keywords
apr
peptides
immunogenicity
immunogenic
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006010934T
Other languages
English (en)
Inventor
Harald Kropshofer
Anne Vogt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602006010934D1 publication Critical patent/DE602006010934D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DE602006010934T 2005-04-20 2006-04-10 Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika Active DE602006010934D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05103199 2005-04-20

Publications (1)

Publication Number Publication Date
DE602006010934D1 true DE602006010934D1 (de) 2010-01-21

Family

ID=37114190

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006010934T Active DE602006010934D1 (de) 2005-04-20 2006-04-10 Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika

Country Status (8)

Country Link
US (1) US20060251664A1 (de)
JP (1) JP4275144B2 (de)
CN (1) CN1877336A (de)
AT (1) ATE451618T1 (de)
CA (1) CA2542104C (de)
DE (1) DE602006010934D1 (de)
ES (1) ES2334936T3 (de)
SG (1) SG126893A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2126584B1 (de) * 2007-03-16 2012-12-19 CovalX AG Direkte massenspektrometrische analyse von auf proteinkomplexe zielenden arzneistoffkandidaten
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
PL3591047T3 (pl) 2012-02-09 2022-12-05 Baylor College Of Medicine Mieszanki peptydowe do wytwarzania wielowirusowych ctl o szerokiej swoistości
US10718781B2 (en) 2014-07-14 2020-07-21 Chugai Seiyaku Kabushiki Kaisha Method for identifying epitope on protein
EP4290238A2 (de) 2015-09-18 2023-12-13 Baylor College of Medicine Identifizierung immunogener antigene aus einem pathogen und korrelation mit klinischer wirksamkeit
WO2018189148A1 (en) 2017-04-10 2018-10-18 Immatics Biotechnologies Gmbh Peptides and combination thereof for use in the immunotherapy against cancers
BR112019020959A2 (pt) 2017-04-10 2020-05-05 Immatics Biotechnologies Gmbh peptídeos e combinações dos mesmos para uso na imunoterapia contra câncer
EP3793604A4 (de) * 2018-05-17 2022-03-02 Immunome, Inc. Epitopmarkierungen der ch3-domäne

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE474851T1 (de) * 2002-10-02 2010-08-15 Hoffmann La Roche Verfahren zur identifizierung antigener peptide

Also Published As

Publication number Publication date
SG126893A1 (en) 2006-11-29
JP4275144B2 (ja) 2009-06-10
JP2006300945A (ja) 2006-11-02
US20060251664A1 (en) 2006-11-09
CN1877336A (zh) 2006-12-13
ES2334936T3 (es) 2010-03-17
CA2542104C (en) 2010-12-07
CA2542104A1 (en) 2006-10-20
ATE451618T1 (de) 2009-12-15

Similar Documents

Publication Publication Date Title
DE602006010934D1 (de) Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika
CY1120822T1 (el) Διαειδικα ειδικη επικρατεια δεσμευσης
WO2004063963A3 (en) Novel proteins with altered immunogenicity
EP2534257A4 (de) Verfahren zur identifikation und isolierung von zellen zur expression von polypeptiden
WO2006046978A3 (en) Cationic peptide-mediated transformation
NZ591704A (en) Peptide vaccines for cancers expressing tumor-associated antigens
DE602005021379D1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
WO2007064919A3 (en) Binding polypeptides with restricted diversity sequences
ATE521708T1 (de) Chimärische, hybrid- und tandem-polypeptide von meningococcus nmb1870
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
MY148646A (en) Anti-psgl-1 antibodies
CO6231038A2 (es) Proteinas de union, incluyendo anticuerpos derivados de anticuerpo y fragmentos de anticuerpo que se unen especificamente a cd154 y sus usos
MX2014005546A (es) Anticuerpos de union de albumina y fragmentos de union de los mismos.
DE60139542D1 (de) Methoden zur herstellung humaner monoklonaler antikörper
AR072897A1 (es) Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5
AR083747A1 (es) Anticuerpos anti-il-23
WO2009051555A3 (en) Modified mhc class i binding peptides
MX2009013824A (es) Proteinas de enlace de antigeno que enlazan par-2.
WO2011022077A3 (en) A nucleic acid cassette for producing recombinant antibodies
WO2007146401A3 (en) Denatured collagen peptides and uses thereof
WO2005012531A3 (en) Antibody cdr polypeptide sequences with restricted diversity
EP4269562A3 (de) Antigenbindende moleküle und verfahren zur verwendung davon
WO2014144911A3 (en) Hybrid immunoglobulin containing non-peptidyl linkage
UA101142C2 (ru) Способ разработки антитела
ATE537187T1 (de) Impfstoffzusammensetzung enthaltend einen klasse- ii-mhc-liganden gekoppelt mit einem antigen, verfahren zu dessen herstellung und dessen verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition